To examine clonality and maturation in mMyc-and hMYC-induced ALL, we next ALLs arrest at the early pro-B cell stage. As expected, hMYC mixed-ALL contained distinct T- well with the percentage of GFP hi /T-ALL vs. GFP lo /B-ALL cells found in each sample ( Fig. 2A) .
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Intriguingly, mMyc B-ALL expressed exclusively ighm while hMYC B-ALL favored ighz 7 9 expression, indicating that mMyc and hMYC might be oncogenic in distinct B cell lineages. To further explore differences between these models, we next identified genes uniquely-8 1 expressed by T-ALL, mMyc/ighm + B-ALL, or hMYC/ighz + B-ALL ( Fig. 2B ). As expected T-8 2
ALLs expressed known T cell lineage markers, yet mMyc/ighm + and hMYC/ighz + B-ALLs were 8 3 transcriptionally distinct. mMyc/ighm + B-ALL expressed gfi1ab, zfhx3, notch1a, nf1b, and 8 4 gtf3aa. By contrast, hMYC/ighz + B-ALL expressed higher cd79a, cd83, mef2cb, and jak2a levels. To further test for differences in these two molecular subtypes of B-ALL, we next performed 8 6 GSEAsig using these same differentially-regulated genes. From this analysis, we uncovered that variants, but rather distinct malignancies that arise in different B cell types with vastly different 9 6 molecular pathway signatures.
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In summary, although zebrafish B cell leukemia models were lacking for many years, our 9 8 analyses reveal two highly-divergent types of B-ALL. This is surprising, as both models utilize Developing a wider array of leukemia models and refining mechanisms that drive their growth, 1 0 9 aggression, and stem cell frequency will surely lead to new insights into human disease. 
